WEB3 days ago · The "Pharmaceutical Testing Services Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued ...
WEB2 days ago · 阿帕他胺,一种新型的非甾体抗雄性激素(AR)抑制剂,是近年来在前列腺癌治疗领域引起广泛关注的药物。它的商品名包括Erleada和Apalutamide,是一种用于治疗非转移性去势抵抗性前列腺癌(nmCRPC)的药物。阿帕他胺通过抑制雄性激素受体,阻断雄性激素信号传导,从而抑制肿瘤生长。 阿帕他胺的 ...